Molecular profiling in determining diagnosis and prognosis of "early" myelodysplastic syndrome
Literature
Read More
NeoGenomics Raises Guidance and Projects 30% Year-Over-Year Revenue Growth in Quarter 2, 2014
Press Release
Read More
A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Literature
Read More
Hyper-plexed biomarker imaging using the MultiOmyx™ platform enables novel systems biology insights for the diagnosis and treatment of disease
Literature
Read More
NeoGenomics Selected by Aurora Diagnostics as Primary Partner for Molecular, FISH, and Immunohistochemistry Testing
Press Release
Read More
NeoGenomics Reports Revenue of $18.2 Million and Adjusted EBITDA of $1.7 million for the First Quarter
Press Release
Read More